B7-33
B7-33 is a single-chain relaxin mimetic. B7-33 is a selective relaxin receptor 1 (RXFP1) agonist. B7-33 binds to RXFP1 and preferentially activates thepERK pathway over cAMP in cells (with RXFP1 expression) . B7-33 is an anti-fibrotic agent. B7-33 has cardioprotective effects[1][2].
Product Specifications
CAS Number
1818415-56-3
UNSPSC
12352209
Target
RXFP Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/b7-33.html
Purity
99.31
Solubility
H2O : 20 mg/mL
Smiles
C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)C)N)=O)[C@H](CC)C)=O)CCCCN)=O)CC(C)C)=O)CO)=O)=O)CCCNC(=N)N)=O)CCC(O)=O)=O)CC(C)C)=O)C(C)C)=O)CCCNC(=N)N)=O)C)=O)CCC(N)=O)=O)[C@H](CC)C)=O)C)=O)[C@H](CC)C)=O)CO)=O)=O)CCSC)=O)CO)=O)[C@@H](C)O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N)=O)=O)CO)=O)CCCNC(=N)N)=O)CCCCN)=O)CO)=O)C=1C=2C(NC1)=CC=CC2
Molecular Formula
C131H229N41O36S
Molecular Weight
2986.54
References & Citations
[1]Alam F, et al. The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy. Biomed Pharmacother. 2023 Apr;160:114370.|[2]Hossain MA, et al. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem Sci. 2016 Jun 1;7 (6) :3805-3819.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog